RE:RE:RE:Medical Community Still Don't Get ItManagement is key. Look at what they've accomplished in the last year alone. My only beef is the number of shares o/s now. I really hope they don't roll back in order to gain appeal with big funds who generally don't like companies with share prices under $20.
Management is solid on another play I'm in too. MTEC on CSE. First tech play on data from Cannabis companies. Already showing revenues and making moves to be the google of cannabis. Take a look for yourself if you think I'm exaggerating
https://cannvasmedtech.com/
Market cap of about $15mill, 38 mill shares out. If one of their many pathways to market opens up, the share price will be multiples of the current price. All imo of course, but take a look.
https://thecse.com/en/listings/life-sciences/cannvas-medtech-inc